Vioquest Pharmaceutl (VOQP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 60 | 90 | 77 | 27 | 21 |
| Receivables | 80 | 110 | 225 | 93 | 62 |
| Inventories | 490 | 510 | 284 | 206 | 195 |
| Other current assets | -230 | -240 | 5 | 3 | 16 |
| TOTAL | $400 | $470 | $591 | $329 | $293 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 15 | 14 | 51 |
| Other Non-Current Assets | 20 | 30 | 30 | 40 | 30 |
| TOTAL | $20 | $30 | $45 | $54 | $81 |
| Total Assets | $450 | $500 | $627 | $369 | $374 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 110 | 70 | 150 | 110 | 77 |
| Accrued Expenses | 50 | 20 | 30 | 20 | 24 |
| TOTAL | $230 | $560 | $349 | $137 | $101 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 400 | 400 | 400 |
| Other Non-Current Liabilities | 0 | 0 | 10 | 10 | 20 |
| TOTAL | $N/A | $N/A | $410 | $410 | $420 |
| Total Liabilities | $230 | $560 | $769 | $557 | $521 |
| Shareholders' Equity | |||||
| Common Shares | 4,260 | 4,220 | 4,150 | 4,120 | 3,977 |
| Retained earnings | -4,440 | -4,290 | -4,322 | -4,327 | -4,161 |
| Other shareholders' equity | 400 | 20 | 31 | 19 | 36 |
| TOTAL | $220 | $-50 | $-142 | $-188 | $-148 |
| Total Liabilities And Equity | $450 | $510 | $627 | $369 | $374 |